Innovative Pharmaceutical Biotech (HKSE:00399) Interest Coverage : 0 (At Loss) (As of Sep. 2024)

Innovative Pharmaceutical Biotech Interest Coverage Chart

Innovative Pharmaceutical Biotech Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Interest Coverage		Get a 7-Day Free Trial					-	-	-	-	-

Innovative Pharmaceutical Biotech Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Interest Coverage	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Innovative Pharmaceutical Biotech's Interest Coverage

For the Specialty Retail subindustry, Innovative Pharmaceutical Biotech's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovative Pharmaceutical Biotech's Interest Coverage Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Innovative Pharmaceutical Biotech's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's Interest Coverage falls into.

Innovative Pharmaceutical Biotech Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Else if Interest Expense is negative and Operating Income is negative, then

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Innovative Pharmaceutical Biotech's Interest Coverage for the fiscal year that ended in Mar. 2024 is calculated as

Here, for the fiscal year that ended in Mar. 2024, Innovative Pharmaceutical Biotech's Interest Expense was HK$-218.10 Mil. Its Operating Income was HK$-13.43 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$671.99 Mil.

Innovative Pharmaceutical Biotech's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Here, for the six months ended in Sep. 2024, Innovative Pharmaceutical Biotech's Interest Expense was HK$-116.24 Mil. Its Operating Income was HK$-7.09 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$55.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Innovative Pharmaceutical Biotech  (HKSE:00399) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Innovative Pharmaceutical Biotech Interest Coverage Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative Pharmaceutical Biotech Business Description